课题基金 / 基金详情

Molecular signaling mechanisms underlying cardiovascular and branchial morphogenesis

Molecular signaling mechanisms underlying cardiovascular and branchial morphogenesis
心血管和鳃形态发生的分子信号机制
批准号:
14370231
负责人:
KURIHARA Hiroki
金额:
$9.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

KURIHARA Hiroki的其他基金

相似基金

相关文献

中文摘要
翻译
1.内皮素-1 (ET-1)是通过诱导Dlx5/6同源盒转录因子调控背腹侧鳃弓形成的关键因子,因此ET-1似乎参与了该区域的基本形态发生程序。dHAND是ET-1信号下游的一个碱基-螺旋-环-螺旋转录因子,被证明参与了血管平滑肌分化的中间过渡。Calpain6被认为是ET-1/dHAND通路下游的一个因子,可能通过修饰细胞骨架参与细胞的形态发生和增殖。TAZ已被确定为Pax3的转录辅激活因子,Pax3是一种参与神经嵴发育的配对型转录因子。已经建立了由ETA受体基因启动子驱动EGFP和TVA(禽逆转录病毒受体)表达的转基因小鼠,为心血管系统和神经嵴发育的研究提供了有用的工具。
英文摘要
1.Endothelin-1 (ET-1) has emerged as a key factor that regulates dorsoventral branchial arch patterning through the induction of Dlx5/6 homoebox transcription factors, thereby ET-1 appears to be involved in basic program of morphogenesis in this region.2.dHAND, a basic-helix-loop-helix transcription factor downstream to the ET-1 signaling, proved to be involved in the intermediate transition of vascular smooth muscle differentiation.3.Calpain6 has been identified as a factor downstream to the ET-1/dHAND pathway, which may participate in cell morphogenesis and proliferation by modification of cytoskeleton.4.TAZ has been identified as a transcriptional coactivator of Pax3, a Paired-type transcription factor involved in neural crest development.5.Transgenic mice in which EGFP and TVA (a receptor for avian retrovirus) expression are driven by the ETA receptor gene promoter has been established and served as a useful tool for researches on the cardiovascular system and neural crest development.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
Yamaguchi Y: "Identification of multiple novel epididymis-specific -defensin isoforms in humans and mice"J.Immunol.. 169. 2516-2523 (2002)
Yamaguchi Y:“人类和小鼠中多种新型附睾特异性防御​​素亚型的鉴定”J.Immunol.. 169. 2516-2523 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ito T: "Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes."Circulation.. 107. 807-810 (2003)
Ito T:“利钠肽对培养的新生大鼠心肌细胞中醛固酮合酶基因表达的抑制作用。”Circulation.. 107. 807-810 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishimatsu H: "Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury : studies on transgenic/knockout mice of adrenomedullin gene."Circ.Res.. 90. 657-663 (2002)
Nishimatsu H:“内源性肾上腺髓质素在调节血管张力和缺血性肾损伤中的作用:对肾上腺髓质素基因转基因/敲除小鼠的研究。”Circ.Res.. 90. 657-663 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishimatsu H: "Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury : studies on transgenic/knockout mice of"Circ.Res.. 90. 657-663 (2002)
Nishimatsu H:“内源性肾上腺髓质素在调节血管张力和缺血性肾损伤中的作用:对转基因/基因敲除小鼠的研究”Circ.Res.. 90. 657-663 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Characterization of neural crest cells migrating into the heart
    • 批准号:
      26670396
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      KURIHARA Hiroki
    • 依托单位:
    Establishment of the concept of broad organ-forming network in cardiovascular formation and models for tissue reconstruction
    • 批准号:
      24249047
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $24.54万
    • 财政年份:
      2012
    • 负责人:
      KURIHARA Hiroki
    • 依托单位:
    Qualitative improvement of aged eggs and development of technologies supporting ART at later ages
    • 批准号:
      23659107
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KURIHARA Hiroki
    • 依托单位:
    Identification of novel cell lineages contributing to cardiovascular development and clarification of mechanisms underlying their fate determination
    • 批准号:
      21390238
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2009
    • 负责人:
      KURIHARA Hiroki
    • 依托单位:
    海外基金